医用磁共振成像MRI设备核心部件

Search documents
助力国产MRI核心部件破局 健信超导科创板IPO申请获受理
Zheng Quan Ri Bao Wang· 2025-05-09 11:17
Group 1 - The core viewpoint of the articles highlights the ongoing effects of the policies introduced by the China Securities Regulatory Commission to deepen the reform of the Sci-Tech Innovation Board, which is aimed at supporting technological innovation and new productivity development [1] - The Sci-Tech Innovation Board has seen an increase in IPO applications, with companies like Ningbo Jianxin Superconducting Technology Co., Ltd. and others being accepted for listing, indicating a clear trend towards "hard technology" in the A-share market [1] - Jianxin Superconducting is recognized as the largest independent supplier of superconducting magnets globally, focusing on the core components of MRI equipment, and has achieved self-designed and large-scale production of mainstream zero-evaporation superconducting magnets [1] Group 2 - Jianxin Superconducting plans to raise 865 million yuan through its IPO, with the funds allocated for projects including the annual production of 600 sets of liquid helium-free superconducting magnets and technological upgrades for high-field medical superconducting magnets [2] - The company has developed the world's first "1.5T liquid helium-free superconducting magnet system," establishing a leading position for China in this next-generation technology [1]
健信超导科创板IPO申请获受理
news flash· 2025-05-09 09:35
Group 1 - The core point of the article is that Ningbo Jianxin Superconducting Technology Co., Ltd. has received acceptance for its IPO application on the Sci-Tech Innovation Board, marking it as the third company to achieve this in 2023 [1] - Jianxin Superconducting is identified as the largest independent supplier of superconducting magnets globally, focusing on the development of core components for medical magnetic resonance imaging (MRI) equipment [1] - The company aims to raise 865 million yuan through its IPO [1]